Elevance Health Inc. closed 27.50% below its 52-week high of $567.26, which the company achieved on September 3rd.

Elevance Health reported nearly $6 billion in 2024 profits including $418 million in the fourth quarter as the health insurer ...

Elevance Health (NYSE: ELV) Q4 2024 Earnings Call Jan 23, 2025, 8:30 a.m. ET ...

Elevance Health reported stronger-than-expected results and raised its dividend as it benefited from higher premiums, ...

Analyst David Windley from Jefferies maintained a Buy rating on Elevance Health (ELV – Research Report) and increased the price target to ...

Whit Mayo, an analyst from Leerink Partners, reiterated the Buy rating on Elevance Health (ELV – Research Report). The associated price target ...

According to Benzinga Pro, Elevance Health's peer group average for short interest as a percentage of float is 5.53%, which ...

Elevance Health Inc (ELV) stock saw a decline, ending the day at $400.96 which represents a decrease of $-0.40 or -0.10% from the prior close of $401.36. The stock opened at $397.16 and touched a low ...

Q4 2024 Earnings Call Transcript January 23, 2025 Elevance Health Inc. beats earnings expectations. Reported EPS is $3.84, expectations were $3.8. Operator: Ladies and gentlemen, thank you for ...

Elevance Health posted $418 million in profit for the fourth quarter of 2024, a figure that surpassed Wall Street's ...

The Indianapolis-based company said it had net income of $1.81 per share. Earnings, adjusted for one-time gains and costs, came to $3.84 per share. The results beat Wall Street expectations. The ...

Elevance Health Q4 revenues hit $45 billion, driven by premium growth and acquisitions. 2025 EPS guidance is $34.15-$34.85, ...